- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
S&S introduces mammography devices
Houston-based S&S Technology has developed the architecture for a hybrid mammography workstation that combines a computer and motorized viewer. The RADX Mammography Workstation places both films and digital images ergonomically for a community in
Houston-based S&S Technology has developed the architecture for a hybrid mammography workstation that combines a computer and motorized viewer. The RADX Mammography Workstation places both films and digital images ergonomically for a community in transition from analog to digital reading. The company has crafted space for two computer monitors beneath the upper belt of a motorized mammography viewer. Space is allowed for the CPU to be mounted in either the left or right side of the viewer's frame, allowing access to the computer's controls. The workstation integrates the company's RADX CrystalViewer film viewer, which was introduced in late 2001.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
